Latest projects

3rd Health Programme (2014-2020)
Alzheimer Europe 2018-2021 [AE2018-2021]
This application for a four-year framework partnership agreement is fully focused on dementia, one of the areas specifically identified as a priority area in the 2017 Call for proposals for operating ...
This application for a four-year framework partnership agreement is fully focused on dementia, one of the areas specifically identified as a priority area in the 2017 Call for proposals for operating grants. It builds on the work carried out by Alzheimer Europe in successive operating grants as part of its current framework partnership agreement (2015-2017).
The activities of Alzheimer Europe under its new 2018-2021 Framework Programme will be responding to the 2009 Commission Communication on a European initiative on Alzheimer's disease and the 2015 Council conclusions on supporting people living with dementia: improving care policies and practices”. The four-year programme aims at assisting the Commission in addressing these recommendations with a particular focus on
1. Providing a voice to people with dementia and their carers
2. Making dementia a European priority and supporting the development of dementia strategies
3. Promoting a rights based approach to dementia
4. Supporting dementia research
5. Strengthening the European dementia movement
Key aspects of the four-year programme of Alzheimer Europe are the Annual Conference bringing together the wider dementia community in Europe and the continued development of the European Working Group of People with Dementia to ensure that the views and experiences of people with dementia are fully integrated in AE activities.
In addition, the four-year programme will support the 2nd EU Joint Action on Dementia which are important initiatives and projects of the third health programme.
Finally, the organisation will identify how best to support the European Solidarity Corps. It will do so by providing traineeship opportunities for young people to work with the AE secretariat and by promoting the European Solidarity Corps amongst its membership.
Start date: 09/03/2018 - End date: 08/03/2022

Call: Operating grants 2018-2021
Topic: 3rd Health Programme (2014-2020)
3rd Health Programme (2014-2020)
European Heart Network - fighting heart disease and stroke [EHN2017]
Main objectives: The three main objectives of the proposal are: prevent avoidable cardiovascular diseases (CVD); strengthen the support for people with CVD; and reinforce cardiovascular research.

Ho...
Main objectives: The three main objectives of the proposal are: prevent avoidable cardiovascular diseases (CVD); strengthen the support for people with CVD; and reinforce cardiovascular research.

How to achieve: The whole population needs to be addressed as well as those at high risk of and those already living with CVD. Therefore, the proposal’s intervention logic is to target policy makers, especially at EU level, to effect changes in policies to achieve small reductions in risk factors across EU’s population of about 500 million, and thus reducing the overall number of people at risk of CVD. The intervention logic, with respect to individuals at high risk for CVD and those already living with it, is to enhance member organisations’ capacity to support patients and fund optimal research. Activities to underpin the intervention logic include a) effective dissemination to EU policy makers of evidence for action (advocacy); b) training and exchange meetings for member organisations (capacity-building and knowledge-sharing); and c) strategic interaction with stakeholders (cooperation/engagement with alliances).

Relevance to the work programme: Two priority areas of the 2017 work programme are: 1) prevention and health determinants; 2) chronic diseases. The proposal’s activities address these head on. CVD make up a substantial part of the chronic disease burden accounting for 19% of all DALYs (on a par with cancer). Tackling CVD is essential for the EU and its member states to achieve international targets on chronic diseases, i.e. a 25% reduction in premature mortality from non-communicable diseases by 2025; and to reduce premature mortality from NCDs by one third by 2030 (Sustainable Development Goals, Goal 3). The proposal’s activities focus strongly on promoting cost-effective promotion and prevention measures in line, in particular, with the EU strategy on diet and nutrition. The proposal is highly relevant to third health programme’s thematic priorities
Start date: 27/02/2018 - End date: 26/02/2022

Call: Operating grants 2018-2021
Topic: 3rd Health Programme (2014-2020)
3rd Health Programme (2014-2020)
Application for an Operating Grant EUPHA [EUPHA]
The European Public Health Association (EUPHA) is a pertinent player in the European public health area. Since our establishment in 1992, EUPHA has been growing and has an increasing influence on the ...
The European Public Health Association (EUPHA) is a pertinent player in the European public health area. Since our establishment in 1992, EUPHA has been growing and has an increasing influence on the public health dialogue in Europe. If awarded the operating grant, EUPHA can continue, expand our activities to influence the European public health policy and contribute to the Third Health Programme. Our main activities can be strengthened with the operating grant. These include:
- Publishing the European Journal of Public Health, in order to strengthening the scientific and independent voice in the field of public health and health services.
- Co-organising an annual European Public Health conference, in order to offer a means for exchanging information and a platform for debate to researchers, policy makers, and practitioners in the field of public health and health services research as well as public health training and education in Europe.
- Advocating public health in Europe by producing a wide range of materials for national public health associations, public health professionals and other stakeholders in Europe, as well as having great visibility to influence public health policy and practice in Europe.
EUPHA’s strong organisation, with 25 years of experience, is a solid basis to contribute to the objectives of the Third Health Programme and to play a key role in the European public health area.


Start date: 09/02/2018 - End date: 08/02/2022
Call: Operating grants 2018-2021
Topic: 3rd Health Programme (2014-2020)
3rd Health Programme (2014-2020)
Strengthening action on health promotion and health equity in the EU: EuroHealthNet’s proposal for 2018-2021 [EuroHealthNet]
EuroHealthNet is a leading Partnership bringing together organisations, agencies and statutory bodies to contribute to our common mission of improving health and tackling health inequalities between a...
EuroHealthNet is a leading Partnership bringing together organisations, agencies and statutory bodies to contribute to our common mission of improving health and tackling health inequalities between and within European States.
Health inequalities are unfair and have a huge economic and social costs. Support from the 3rd Health Programme will enable EuroHealthNet to contribute: (1) to reducing health inequalities in Europe, by encouraging countries to act, through consolidated action on the social determinants of health, with a particular focus on children and young people; (2) to reducing the burden of chronic diseases and improving mental health and well-being; (3) to contribute to more innovative, sustainable and equitable health system, by strengthening the role of promotion and disease prevention; and (4) to achieving a high quality and effective European Partnership for improving health equity and well-being.

EuroHealthNet will realise these objectives through cross-cutting work in our three Platforms and through our core services:
POLICY: we monitor, analyse and influence policy at EU and national level and across sectors. We provide guidance to the Partnership about EU policies and vice versa.
PRACTICE: we build capacity and share knowledge among members and associates so that they can learn from and inspire one another, reinforce resources, shape initiatives and implement more ‘state of the art’ approaches in the relevant areas.
RESEARCH: we build the evidence base for effective policies and practices and share the latest evidence with researchers, policy makers and practitioners.
Our core services, which involve our highly effective communication activities, the coordination of Thematic Working Groups (TWIGs), membership development, administration and evaluation, reinforce our work. Our 2018-21 work programme, which focuses on one strategic objective per year, directly contributes to 3/4ths of the objectives of the 3rd Health Programme.
Start date: 06/02/2018 - End date: 05/02/2022

Call: Operating grants 2018-2021
Topic: 3rd Health Programme (2014-2020)
3rd Health Programme (2014-2020)
Unified European Registry for Inherited Metabolic Disorders [U-IMD]
More than 700 inherited metabolic diseases (IMDs) have been identified so far. Each single IMD is a rare condition, but collectively IMDs are affecting at least one in 500 newborns. Clinical presentat...
More than 700 inherited metabolic diseases (IMDs) have been identified so far. Each single IMD is a rare condition, but collectively IMDs are affecting at least one in 500 newborns. Clinical presentation of IMDs is wide-ranging from involvement of single organ systems to multi-systemic disease, confronting patients with significant and often severe health problems resulting in high morbidity, reduced life expectancy, and low quality of life.
For a limited number of IMDs networking activities already exist on a European or international level. The E-IMD, E-HOD and iNTD family of IMD registries has a relevant impact on improving the health of patients with IMDs and facilitates post-authorisation safety studies (PASS) for orphan drugs. However existing registries still do exclude a significant portion of IMDs and do not fulfill all core recommendations made by the European Union Committee of Experts on Rare Diseases (EUCERD). The recent inception of the European Reference Network for Hereditary Metabolic Diseases (MetabERN) lays the foundation for the development of an overarching European IT platform for IMD registries.
The project consists of 3 components: (1) a novel registry platform for all known IMDs, (2) an upgrade of existing IMD registries and (3) a collaboration with the European Rare Kidney Disease Reference Network (ERKNet). The new Unified European Registry for Inherited Metabolic Diseases (U-IMD) will encompass all known IMDs, fully implementing EUCERD recommendations. Data modules developed for U-IMD will be integrated in the existing IMD registries, with the iNTD registry as pilot, thus reaching interoperability of patient records. MetabERN and ERKNet will develop a common standard for minimal core data sets.
The U-IMD registry will follow an open multiple stakeholder approach, explicitly seeking collaborations with national and EU level health authorities, other scientific networks and consortia, patient and parent organizations and industry.

Start date: 01/02/2018 - End date: 31/01/2021

Call: Rare diseases - support for New Registries
Topic: 4.2 Support Member States, patient organisations and stakeholders by coordinated action at Union level in order to effectively help patients affected by rare diseases. This includes...
Topic: 4.2 Support Member States, patient organisations and stakeholders by coordinated action at Union level in order to effectively help patients affected by rare diseases. This includes the creation of reference networks (in compliance with point 4.1), Union wide information databases and registries for rare diseases based on common criteria.